Nobuo Mizue
Overview
Explore the profile of Nobuo Mizue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hatakeyama N, Hori T, Yamamoto M, Mizue N, Igarashi K, Suzuki N, et al.
Int J Hematol
. 2014 Jul;
100(3):211-3.
PMID: 25034749
No abstract available.
2.
Pacienza N, Yoshimitsu M, Mizue N, Au B, Wang J, Fan X, et al.
Mol Ther
. 2012 Apr;
20(7):1454-61.
PMID: 22472949
Fabry disease is a lysosomal storage disorder caused by a deficiency of α-galactosidase A (α-gal A) activity that results in progressive globotriaosylceramide (Gb(3)) deposition. We created a fully congenic nonobese...
3.
Kuramitsu M, Sato-Otsubo A, Morio T, Takagi M, Toki T, Terui K, et al.
Blood
. 2012 Jan;
119(10):2376-84.
PMID: 22262766
Fifty percent of Diamond-Blackfan anemia (DBA) patients possess mutations in genes coding for ribosomal proteins (RPs). To identify new mutations, we investigated large deletions in the RP genes RPL5, RPL11,...
4.
Hatakeyama N, Hori T, Yamamoto M, Mizue N, Inazawa N, Igarashi K, et al.
Int J Hematol
. 2011 Sep;
94(4):372-377.
PMID: 21904952
Long-term venous access is essential when treating malignant diseases. We reviewed our experience with peripherally inserted central venous catheters (PICC) in children suffering from various malignancies with regard to catheter...
5.
Maekawa Y, Mizue N, Chan A, Shi Y, Liu Y, Dawood S, et al.
Circulation
. 2009 Sep;
120(14):1401-14.
PMID: 19770394
Background: The innate immune system greatly contributes to the inflammatory process after myocardial infarction (MI). Interleukin-1 receptor-associated kinase-4 (IRAK-4), downstream of Toll/interleukin-1 receptor signaling, has an essential role in regulating...
6.
Loisel-Meyer S, Felizardo T, Mariotti J, Mossoba M, Foley J, Kammerer R, et al.
Mol Cancer Ther
. 2009 Mar;
8(3):692-702.
PMID: 19276164
The applicability of immunotherapy would be dramatically broadened to a greater number of recipients if direct "off-the-shelf" products could be engineered to engender functionally potent immune responses against true "self"-tumor...
7.
Suzuki N, Hatakeyama N, Yamamoto M, Mizue N, Kuroiwa Y, Yoda M, et al.
Int J Hematol
. 2007 Jan;
85(1):70-2.
PMID: 17261504
Patients with chronic granulomatous disease (CGD) complicated by antimycotics-refractory invasive aspergillosis have an extremely poor prognosis if they cannot undergo allogeneic hematopoietic stem cell transplantation from a suitable related donor...
8.
Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report
Yamamoto M, Suzuki N, Hatakeyama N, Mizue N, Hori T, Kuroiwa Y, et al.
J Pediatr Hematol Oncol
. 2006 Jun;
28(5):286-9.
PMID: 16772877
The prognosis of stage IV malignant rhabdoid tumor of the kidney (MRTK) has been extremely poor. However, a combination of ICE (ifosfamide, carboplatin, and etoposide) and VDCy (vincristine, doxorubicin, and...
9.
Hatakeyama N, Tamura Y, Sahara H, Suzuki N, Suzuki K, Hori T, et al.
Exp Hematol
. 2006 Feb;
34(2):197-207.
PMID: 16459188
Objective: Several studies have demonstrated that dendritic cells (DCs) pulsed with tumor lysate or apoptotic tumor cells can elicit effective T-cell responses. This technique does not require the identification of...
10.
Kuroiwa Y, Suzuki N, Yamamoto M, Hatakeyama N, Hori T, Mizue N
Rinsho Ketsueki
. 2006 Jan;
46(11):1179-86.
PMID: 16440800
Transient abnormal myelopoiesis (TAM) is usually a self-limiting myeloproliferative disorder observed in approximately 10% of newborn infants with Down syndrome. However, progressive liver fibrosis may occur in patients with TAM...